Filing Flows › Champions Oncology (CSBR) › Q4 FY26 › vs Q4 FY25
Champions Oncology (CSBR) Q4 FY26 vs Q4 FY25 (year over year)
Champions Oncology's revenue rose $1.5M (+12%) from $12.4M in Q4 FY25 to $13.8M in Q4 FY26.
Champions Oncology, Q4 FY26: revenue $13.8M (+12% year over year), operating margin -3.8%, net loss $667K, operating cash flow −$2.0M. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $13.8M | $12.4M | $1.5M | +12% |
| Net loss | $667K | $1.8M | −$1.2M | -64% |
| Costs & expenses | $14.5M | $14.4M | $167K | +1% |
| Operating costs | $14.4M | $14.4M | −$5K | 0% |
| Income tax | $172K | −$129K | $301K | — |
| Cost of revenue | $6.8M | $7.3M | −$461K | -6% |
| Research & development | $2.1M | $2.0M | $152K | +8% |
| Sales & marketing | $2.8M | $2.3M | $489K | +21% |
| General & admin | $2.6M | $2.5M | $107K | +4% |
| Operating cash sources | $2.7M | −$6.3M | $9.0M | — |
| Depreciation & amortization | $300K | $400K | −$100K | -25% |
| Share-based compensation | $357K | $131K | $226K | +173% |
| Cash used in operations | $2.0M | −$6.9M | $8.9M | — |
| Net loss absorbed | $667K | $1.8M | −$1.2M | -64% |
| Working capital & other | $2.0M | −$8.2M | $10.2M | — |
Questions
How much did Champions Oncology's revenue grow year over year in Q4 FY26?
Champions Oncology's revenue rose $1.5M (+12%) from $12.4M in Q4 FY25 to $13.8M in Q4 FY26.